129 related articles for article (PubMed ID: 9223425)
1. Increased MAPK expression and activity in primary human hepatocellular carcinoma.
Schmidt CM; McKillop IH; Cahill PA; Sitzmann JV
Biochem Biophys Res Commun; 1997 Jul; 236(1):54-8. PubMed ID: 9223425
[TBL] [Abstract][Full Text] [Related]
2. Activation of mitogen-activated protein kinases/extracellular signal-regulated kinases in human hepatocellular carcinoma.
Ito Y; Sasaki Y; Horimoto M; Wada S; Tanaka Y; Kasahara A; Ueki T; Hirano T; Yamamoto H; Fujimoto J; Okamoto E; Hayashi N; Hori M
Hepatology; 1998 Apr; 27(4):951-8. PubMed ID: 9537433
[TBL] [Abstract][Full Text] [Related]
3. Altered expression of mitogen-activated protein kinases in a rat model of experimental hepatocellular carcinoma.
McKillop IH; Schmidt CM; Cahill PA; Sitzmann JV
Hepatology; 1997 Dec; 26(6):1484-91. PubMed ID: 9397988
[TBL] [Abstract][Full Text] [Related]
4. [The role of extracellular signal-regulated kinase/mitogen-activated protein kinase pathway in multidrug resistance of hepatocellular carcinoma].
Zhu H; Chen XP; Luo SF; Guan J; Zhang WG; Zhang BX; Mao CP
Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(13):917-20. PubMed ID: 17953842
[TBL] [Abstract][Full Text] [Related]
5. Altered Gq/G11 guanine nucleotide regulatory protein expression in a rat model of hepatocellular carcinoma: role in mitogenesis.
McKillop IH; Schmidt CM; Cahill PA; Sitzmann JV
Hepatology; 1999 Feb; 29(2):371-8. PubMed ID: 9918912
[TBL] [Abstract][Full Text] [Related]
6. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
[TBL] [Abstract][Full Text] [Related]
7. Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation.
Sun CK; Man K; Ng KT; Ho JW; Lim ZX; Cheng Q; Lo CM; Poon RT; Fan ST
Carcinogenesis; 2008 Nov; 29(11):2096-105. PubMed ID: 18765415
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of extracellular signal-regulated protein kinase and its correlation with proliferation in human hepatocellular carcinoma.
Tsuboi Y; Ichida T; Sugitani S; Genda T; Inayoshi J; Takamura M; Matsuda Y; Nomoto M; Aoyagi Y
Liver Int; 2004 Oct; 24(5):432-6. PubMed ID: 15482339
[TBL] [Abstract][Full Text] [Related]
9. MEK/ERK-dependent uPAR expression is required for motility via phosphorylation of P70S6K in human hepatocarcinoma cells.
Bessard A; Frémin C; Ezan F; Coutant A; Baffet G
J Cell Physiol; 2007 Aug; 212(2):526-36. PubMed ID: 17427199
[TBL] [Abstract][Full Text] [Related]
10. Dual-specificity phosphatase 1 ubiquitination in extracellular signal-regulated kinase-mediated control of growth in human hepatocellular carcinoma.
Calvisi DF; Pinna F; Meloni F; Ladu S; Pellegrino R; Sini M; Daino L; Simile MM; De Miglio MR; Virdis P; Frau M; Tomasi ML; Seddaiu MA; Muroni MR; Feo F; Pascale RM
Cancer Res; 2008 Jun; 68(11):4192-200. PubMed ID: 18519678
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of extracellular signal regulated kinase expression and its relation to treatment of hepatocellular carcinoma.
Osada S; Kanematsu M; Imai H; Goshima S; Sugiyama Y
J Am Coll Surg; 2005 Sep; 201(3):405-11. PubMed ID: 16125074
[TBL] [Abstract][Full Text] [Related]
12. Overactivation of the MEK/ERK pathway in liver tumor cells confers resistance to TGF-{beta}-induced cell death through impairing up-regulation of the NADPH oxidase NOX4.
Caja L; Sancho P; Bertran E; Iglesias-Serret D; Gil J; Fabregat I
Cancer Res; 2009 Oct; 69(19):7595-602. PubMed ID: 19773433
[TBL] [Abstract][Full Text] [Related]
13. Alterations in guanine nucleotide regulatory protein expression and activity in human hepatocellular carcinoma.
Schmidt CM; McKillop IH; Cahill PA; Sitzmann JV
Hepatology; 1997 Nov; 26(5):1189-94. PubMed ID: 9362361
[TBL] [Abstract][Full Text] [Related]
14. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.
Liu L; Cao Y; Chen C; Zhang X; McNabola A; Wilkie D; Wilhelm S; Lynch M; Carter C
Cancer Res; 2006 Dec; 66(24):11851-8. PubMed ID: 17178882
[TBL] [Abstract][Full Text] [Related]
15. Differential sensitivity of chemoresistant neuroblastoma subtypes to MAPK-targeted treatment correlates with ERK, p53 expression, and signaling response to U0126.
Eppstein AC; Sandoval JA; Klein PJ; Woodruff HA; Grosfeld JL; Hickey RJ; Malkas LH; Schmidt CM
J Pediatr Surg; 2006 Jan; 41(1):252-9. PubMed ID: 16410143
[TBL] [Abstract][Full Text] [Related]
16. Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors.
Yoshida T; Hisamoto T; Akiba J; Koga H; Nakamura K; Tokunaga Y; Hanada S; Kumemura H; Maeyama M; Harada M; Ogata H; Yano H; Kojiro M; Ueno T; Yoshimura A; Sata M
Oncogene; 2006 Oct; 25(45):6056-66. PubMed ID: 16652141
[TBL] [Abstract][Full Text] [Related]
17. The effect of doxorubicin on MEK-ERK signaling predicts its efficacy in HCC.
Choi J; Yip-Schneider M; Albertin F; Wiesenauer C; Wang Y; Schmidt CM
J Surg Res; 2008 Dec; 150(2):219-26. PubMed ID: 18468633
[TBL] [Abstract][Full Text] [Related]
18. Biological effects of human insulin receptor substrate-1 overexpression in hepatocytes.
Tanaka S; Mohr L; Schmidt EV; Sugimachi K; Wands JR
Hepatology; 1997 Sep; 26(3):598-604. PubMed ID: 9303488
[TBL] [Abstract][Full Text] [Related]
19. Role of p38 mitogen-activated protein kinase and extracellular signal-regulated protein kinase kinase in adenosine A2B receptor-mediated interleukin-8 production in human mast cells.
Feoktistov I; Goldstein AE; Biaggioni I
Mol Pharmacol; 1999 Apr; 55(4):726-34. PubMed ID: 10101031
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of death-associated protein-kinase expression in hepatocellular carcinomas.
Matsumoto H; Nagao M; Ogawa S; Kanehiro H; Hisanaga M; Ko S; Ikeda N; Fujii H; Koyama F; Mukogawa T; Nakajima Y
Anticancer Res; 2003; 23(2B):1333-41. PubMed ID: 12820391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
